| Dr Adam Michael Nadolski, MD | |
|
200 W Arbor Dr, San Diego, CA 92103-9000 | |
| (619) 543-6222 | |
| Not Available |
| Full Name | Dr Adam Michael Nadolski |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 200 W Arbor Dr, San Diego, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447698915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 131962 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uc San Diego Health Hillcrest - Hillcrest Med Ctr | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 3577476761 | 1692 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.
A new method in which a number of operations are performed simultaneously can provide people with tetraplegia with a better grip function and the ability to open their hand. This method also shortens the patient's rehabilitation period by at least three months, reveals a doctoral thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.
It is well known that moderate drinking can have positive health benefits - for instance, a couple of glasses of red wine a day can be good for the heart.
› Verified 8 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.
A new method in which a number of operations are performed simultaneously can provide people with tetraplegia with a better grip function and the ability to open their hand. This method also shortens the patient's rehabilitation period by at least three months, reveals a doctoral thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.
It is well known that moderate drinking can have positive health benefits - for instance, a couple of glasses of red wine a day can be good for the heart.
› Verified 8 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780870899 PECOS PAC ID: 6406760131 Enrollment ID: O20031117000940 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.
A new method in which a number of operations are performed simultaneously can provide people with tetraplegia with a better grip function and the ability to open their hand. This method also shortens the patient's rehabilitation period by at least three months, reveals a doctoral thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.
It is well known that moderate drinking can have positive health benefits - for instance, a couple of glasses of red wine a day can be good for the heart.
› Verified 8 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578672184 PECOS PAC ID: 3577476761 Enrollment ID: O20031211000464 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.
A new method in which a number of operations are performed simultaneously can provide people with tetraplegia with a better grip function and the ability to open their hand. This method also shortens the patient's rehabilitation period by at least three months, reveals a doctoral thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.
It is well known that moderate drinking can have positive health benefits - for instance, a couple of glasses of red wine a day can be good for the heart.
› Verified 8 days ago
| Entity Name | Emergency Medicine Group Of Encinitas, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902805179 PECOS PAC ID: 7618929381 Enrollment ID: O20050210000997 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.
A new method in which a number of operations are performed simultaneously can provide people with tetraplegia with a better grip function and the ability to open their hand. This method also shortens the patient's rehabilitation period by at least three months, reveals a doctoral thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.
It is well known that moderate drinking can have positive health benefits - for instance, a couple of glasses of red wine a day can be good for the heart.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Michael Nadolski, MD Po Box 232410, San Diego, CA 92193-2410 Ph: () - | Dr Adam Michael Nadolski, MD 200 W Arbor Dr, San Diego, CA 92103-9000 Ph: (619) 543-6222 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.
A new method in which a number of operations are performed simultaneously can provide people with tetraplegia with a better grip function and the ability to open their hand. This method also shortens the patient's rehabilitation period by at least three months, reveals a doctoral thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.
It is well known that moderate drinking can have positive health benefits - for instance, a couple of glasses of red wine a day can be good for the heart.
› Verified 8 days ago
Sarah Wilkinson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr # 8819, San Diego, CA 92103 Phone: 956-458-9885 | |
Dr. Ramandeep Singh Dhillon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5454 El Cajon Blvd, San Diego, CA 92115 Phone: 619-515-2400 | |
Mina Kyrollus Ghobrial, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 | |
Dr. Timothy Stuart Hinman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 4th Ave, San Diego, CA 92101 Phone: 858-499-2600 | |
Dr. Peter D. Aldrich, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 15025 Innovation Dr, San Diego, CA 92128 Phone: 858-554-8638 | |
Dr. Matthew J. Perl, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15004 Innovation Dr, San Diego, CA 92128 Phone: 858-605-7171 | |
Jeffrey Adam Bush, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-528-5000 |